These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8664408)

  • 21. The potential oncogenic effect of tamoxifen on the endometrium.
    Berlière M; Galant C; Donnez J
    Hum Reprod; 1999 May; 14(5):1381-3. PubMed ID: 10325299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prescription pattern of Chinese herbal products that contain dang-qui and risk of endometrial cancer among tamoxifen-treated female breast cancer survivors in Taiwan: a population-based study.
    Wu CT; Lai JN; Tsai YT
    PLoS One; 2014; 9(12):e113887. PubMed ID: 25485843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis.
    Amir E; Seruga B; Niraula S; Carlsson L; Ocaña A
    J Natl Cancer Inst; 2011 Sep; 103(17):1299-309. PubMed ID: 21743022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of endometrial cancer after tamoxifen treatment of breast cancer.
    van Leeuwen FE; Benraadt J; Coebergh JW; Kiemeney LA; Gimbrère CH; Otter R; Schouten LJ; Damhuis RA; Bontenbal M; Diepenhorst FW
    Lancet; 1994 Feb; 343(8895):448-52. PubMed ID: 7905955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tamoxifen and risk of large bowel cancer in women with breast cancer.
    Newcomb PA; Solomon C; White E
    Breast Cancer Res Treat; 1999 Feb; 53(3):271-7. PubMed ID: 10369073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uterine side effects of tamoxifen: a need for systematic pretreatment screening.
    Berlière M; Charles A; Galant C; Donnez J
    Obstet Gynecol; 1998 Jan; 91(1):40-4. PubMed ID: 9464718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endometrial cancer and tamoxifen.
    Burke C
    Clin J Oncol Nurs; 2005 Apr; 9(2):247-9. PubMed ID: 15853168
    [No Abstract]   [Full Text] [Related]  

  • 29. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Chin J; Konje JC; Hickey M
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of Chinese herbal products and its influence on tamoxifen induced endometrial cancer risk among female breast cancer patients: a population-based study.
    Tsai YT; Lai JN; Wu CT
    J Ethnopharmacol; 2014 Sep; 155(2):1256-62. PubMed ID: 25048609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endolymphatic stromal myosis associated with tamoxifen use.
    Eddy GL; Mazur MT
    Gynecol Oncol; 1997 Feb; 64(2):262-4. PubMed ID: 9038273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surveillance for uterine abnormalities in tamoxifen-treated breast carcinoma survivors: a community based study.
    Althuis MD; Sexton M; Langenberg P; Bush TL; Tkaczuk K; Magaziner J; Khoo L
    Cancer; 2000 Aug; 89(4):800-10. PubMed ID: 10951343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endometrial cancer and tamoxifen. Discussion apropos of a series of cases].
    Sasco AJ; Ah-Song R; Gendre I; Zlatoff P; Bobin JY; Hallonet P; Leduc B
    Bull Cancer; 1997 Jan; 84(1):51-60. PubMed ID: 9180860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of cyclins A and E in endometrial carcinogenesis in breast cancer patients under tamoxifen treatment.
    Metwally AM; Refaat LA; Shaaban H; Megm S; Emara M; Tohamy AA; Sinna EA; Khaled H
    J Egypt Natl Canc Inst; 2013 Dec; 25(4):193-8. PubMed ID: 24207091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients.
    Cohen I; Bernheim J; Azaria R; Tepper R; Sharony R; Beyth Y
    Gynecol Oncol; 1999 Oct; 75(1):136-41. PubMed ID: 10502440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gynecologic tumors in tamoxifen-treated women with breast cancer.
    Seoud MA; Johnson J; Weed JC
    Obstet Gynecol; 1993 Aug; 82(2):165-9. PubMed ID: 8393156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re: second cancers after adjuvant tamoxifen therapy for breast cancer.
    Rutqvist LE
    J Natl Cancer Inst; 1996 Oct; 88(20):1497-9; author reply, 1497-9. PubMed ID: 8841030
    [No Abstract]   [Full Text] [Related]  

  • 38. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group.
    Rutqvist LE; Johansson H; Signomklao T; Johansson U; Fornander T; Wilking N
    J Natl Cancer Inst; 1995 May; 87(9):645-51. PubMed ID: 7752269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer.
    Fornander T; Hellström AC; Moberger B
    J Natl Cancer Inst; 1993 Nov; 85(22):1850-5. PubMed ID: 8230266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risks of second malignancies after breast cancer treatment: Long-term results.
    Bazire L; De Rycke Y; Asselain B; Fourquet A; Kirova YM
    Cancer Radiother; 2017 Feb; 21(1):10-15. PubMed ID: 28034681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.